The Liposomal Drug Delivery Devices Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Liposomes have been Widely Explored as Drug Carriers for Improving Therapeutic Agent Delivery
Liposomes have been widely explored as drug carriers for improving therapeutic agent delivery to target body sites. As a result, a number of breakthroughs have been achieved, possibly making this technology helpful for the treatment of particular ailments. Liposomes increase medicine absorption while avoiding or minimising quick disintegration and adverse effects, prolonging the biological half-life and lowering toxicity. Liposomes are biocompatible, biodegradable, inert, and non-immunogenic lipids thus making them unique for as drug delivery carrier.
Due to their low immunogenicity, decreased toxicity, and capacity to carry larger cargo to target locations, liposomal formulations have witnessed a significant increase in scientific attention over the last decade, and have been demonstrated to be safer than viral vectors. Liposome-based drug delivery methods are used to administer anti-cancer, anti-fungal, and anti-inflammatory drugs, as well as therapeutic gene therapy.
Rising Awareness of Targeted Drug Delivery to Boost Market Growth
The rise in awareness of targeted drug delivery, an increase in cancer occurrences, and an increase in the functionalities of liposomes are likely to drive the growth of the liposomal medicines market in the forecast year. The increase in the price of liposomal drug delivery devices, on the other hand, is projected to challenge liposomal drug delivery devices industry expansion over the forecast period.
Furthermore, the growing adoption of liposomes in clinics due to their low toxicity and great efficacy will give further prospects for the liposomal pharmaceuticals market to develop in the future years. The rapid half-life cycle of liposomes, on the other hand, might hinder the market for liposomal medications in the near future.
North America liposomal drug delivery devices market is anticipated to lead the worldwide liposomal drug delivery market in 2022, and it is expected to continue to do so during the forecast period, owing to increased demand from the United States. Treatment of patients with ovarian cancer, AIDS-related Kaposi's sarcoma, and fungal infections are among the major treatments driving regional market expansion. Furthermore, Asia Pacific liposomal drug delivery devices are expected to grow at the highest CAGR of 11.5% from 2022 to 2032. Demand for Asia-Pacific liposomal drug delivery devices market is expected to be fueled by China, India, and Japan. With rising concerns of stibanate resistance, India accounts for around half of worldwide visceral leishmaniasis (VL) infections, which is likely to enhance regional growth over the projection period.
What Questions Should You Ask before Buying a Market Research Report?
• How is the liposomal drug delivery devices market evolving?
• What is driving and restraining the liposomal drug delivery devices market?
• How will each liposomal drug delivery devices submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
• How will the market shares for each liposomal drug delivery devices submarket develop from 2022 to 2032?
• What will be the main driver for the overall market from 2022 to 2032?
• Will leading liposomal drug delivery devices markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
• Who are the leading players and what are their prospects over the forecast period?
• What are the Liposomal Drug Delivery Devices projects for these leading companies?
• How will the industry evolve during the period between 2022 and 2032? What are the implications of Liposomal Drug Delivery Devices projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the liposomal drug delivery devices market?
• Where is the liposomal drug delivery devices market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the liposomal drug delivery devices market today, and over the next 10 years:
• Our 535-page report provides 337 tables and 323 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the liposomal drug delivery devices market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
The report delivers exclusive COVID-19 variations and economic data specific to your market.
Forecasts to 2032 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Liposomal Drug Delivery Devices prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Type
• Liposomal Doxorubicin
• Liposomal Paclitaxel
• Liposomal Amphotericin B
Technology
• Stealth Liposome Technology
• NonPEGylated Liposome Technology
• DepoFoam Liposome Technology
Application
• Fungal Diseases
• Cancer Therapy
• Pain Management
• Viral Vaccines
• Photodynamic Therapy
End-user
• Hospitals
• Diagnostic Centers
• Ambulatory Surgery Centers/Clinics
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:
North America
• U.S.
• Canada
Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa
• GCC
• South Africa
• Rest of Middle East & Africa
The report also includes profiles and for some of the leading companies in the Liposomal Drug Delivery Devices Market, 2022 to 2032, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• AbbVie Inc. (AbbVie)
• Bavarian Nordic A/S
• Catalent, Inc.
• Charles River Laboratories International, Inc.
• Emergent BioSolutions Inc.
• Eurofins Scientific SE
• FUJIFILM Holdings Corporation
• GlaxoSmithKline PLC
• Kemwell Biopharma
• Lonza Group AG (Lonza)
• Merck KGaA
• Pfizer Inc. (Pfizer)
• Richter-Helm BioLogics
• Samsung Biologics Co Ltd
• Sanofi SA
• Serum Institute of India
• Siegfried Holding AG
• Thermo Fisher Scientific Inc.
• Wacker Biotech B.V.
• WuXi Biologics Cayman Inc
Overall world revenue for Liposomal Drug Delivery Devices Market, 2022 to 2032 in terms of value the market will surpass US$4,091.1 million in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Liposomal Drug Delivery Devices Market, 2022 to 2032 report help you?
In summary, our 530+ page report provides you with the following knowledge:
• Revenue forecasts to 2032 for Liposomal Drug Delivery Devices Market, 2022 to 2032 Market, with forecasts for type, technology, application, and end-user, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2032 for four regional and 20 key national markets – See forecasts for the Liposomal Drug Delivery Devices Market, 2022 to 2032 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 20 of the major companies involved in the Liposomal Drug Delivery Devices Market, 2022 to 2032.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Liposomal Drug Delivery Devices Market, 2022 to 2032, market-leading companies. You will find data, trends and predictions.
'
1. Report Overview
1.1 Introduction to Liposomal Drug Delivery Devices Market
1.2 Liposomal Drug Delivery Devices Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 COVID-19 Impact: Recovery Scenarios
1.7.2 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About
2 Executive Summary
3 Market Dynamics
3.1 Drivers
3.1.1 Liposomal formulations assisting the delivery of nanomedicines
3.1.2 Growing application of Liposomal drug delivery for cancer treatment to drive market growth
3.1.3 Adoption of Nanomedicines to Boost Market Growth
3.1.4 Rising Product Approvals to Fuel Market Growth
3.1.5 Technological Advancements in Liposomal-based Medicinal Formulations to Spur Market Demand
3.2 Restraints
3.2.1 Lack of Standard Regulations to Stifle Market Growth
3.2.2 High Cost of Liposomal Drug Delivery Devices
3.2.3 Sterilization and Encapsulation Efficacy Issue to Restrain Market Growth
3.3 Opportunities
3.3.1 Emergence of COVID-19 Anticipated to Offer Lucrative Growth Opportunities
3.3.2 Nanomedicines Are Projected to Offer Lucrative Growth Prospects for Market Players
3.4 SWOT Analysis
3.4.1 Market Strengths
3.4.2 Market Weaknesses
3.4.3 Market Opportunities
3.4.4 Market Threats
3.5 Porter’s Five Forces Analysis
3.5.1 Competitive Rivalry (High)
3.5.2 Supplier Power (Low to Medium)
3.5.3 Buyer Power (Medium)
3.5.4 Threat from Substitutes (Low)
3.5.5 Threat of New Entrants (Low to Medium)
3.6 PEST Analysis
3.6.1 Political Factors Impacting Liposomal Drug Delivery Devices Market
3.6.2 Economic Factors Impacting Liposomal Drug Delivery Devices Market
3.6.3 Social Factors Impacting Liposomal Drug Delivery Devices Market
3.6.4 Technological Factors Impacting Liposomal Drug Delivery Devices Market
4 Liposomal Drug Delivery Devices Market by Type
4.1 Liposomal Doxorubicin Segment Market Forecast, 2022-2032
4.1.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.2 Liposomal Paclitaxel Segment Market Forecast, 2022-2032
4.2.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
4.3 Liposomal Amphotericin B Segment Market Forecast, 2022-2032
4.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5 Liposomal Drug Delivery Devices Market by Technology
5.1 Stealth Liposome Technology Segment Market Forecast, 2022-2032
5.1.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.2 Non-PEGylated Liposome Technology Segment Market Forecast, 2022-2032
5.2.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
5.3 DepoFoam Liposome Technology Segment Market Forecast, 2022-2032
5.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6 Liposomal Drug Delivery Devices Market by Application
6.1 Fungal Diseases Segment Market Forecast, 2022-2032
6.1.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.2 Cancer Therapy Segment Market Forecast, 2022-2032
6.2.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.3 Pain Management Segment Market Forecast, 2022-2032
6.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.4 Viral Vaccines Segment Market Forecast, 2022-2032
6.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
6.5 Photodynamic Therapy Segment Market Forecast, 2022-2032
6.5.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7 Liposomal Drug Delivery Devices Market by End-User
7.1 Hospitals Segment Market Forecast, 2022-2032
7.1.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7.2 Diagnostic Centers (Radio Imaging) Segment Market Forecast, 2022-2032
7.2.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
7.3 Ambulatory Surgery Centers/Clinics Segment Market Forecast, 2022-2032
7.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
8 Regional and Leading National Liposomal Drug Delivery Devices Market Forecasts 2022-2032
8.1 Introduction
8.2 Global Liposomal Drug Delivery Devices Market by Region Forecast 2022-2032
8.3 COVID-19 Impact Recovery Scenarios (V, U, W, L)
9 North America Liposomal Drug Delivery Devices Market
9.1 Introduction
9.2 North America Liposomal Drug Delivery Devices Market by Country, Forecast 2022-2032
9.3 North America Liposomal Drug Delivery Devices Market Forecast by Type
9.4 North America Liposomal Drug Delivery Devices Market Forecast by Technology
9.5 North America Liposomal Drug Delivery Devices Market Forecast by Application
9.6 North America Liposomal Drug Delivery Devices Market Forecast by End-User
9.7 U.S. Liposomal Drug Delivery Devices Market Forecast, 2022-2032
9.7.1 Growing Burden of Genetic Disorders to Boost U.S. Liposomal Drug Delivery Devices Market Growth
9.7.2 Rising Burden of Cancer to Fuel Regional Growth
9.7.3 U.S. Witnessing Significant Investment from Market Players
9.7.4 Pacira Announces FDA Approval of Supplemental New Drug Application For Exparel® (Bupivacaine Liposome Injectable Suspension) in Pediatric Patients
9.7.5 COVID-19 Impact Recovery Scenarios (V, U, W, L): U.S. Liposomal Drug Delivery Devices Market Forecast, 2022-2032
9.8 Canada Liposomal Drug Delivery Devices Market Forecast, 2022-2032
9.8.1 Ageing Population Across the Region to Boost Market Growth
9.8.2 Growing Cancer Burden to Offer Lucrative Growth Prospects for Canadian Market Players
9.8.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Canada Liposomal Drug Delivery Devices Market Forecast, 2022-2032
10 Europe Liposomal Drug Delivery Devices Market
10.1 Introduction
10.2 Europe Liposomal Drug Delivery Devices Market by Country, Forecast 2022-2032
10.3 Europe Liposomal Drug Delivery Devices Market Forecast by Type
10.4 Europe Liposomal Drug Delivery Devices Market Forecast by Technology
10.5 Europe Liposomal Drug Delivery Devices Market Forecast by Application
10.6 Europe Liposomal Drug Delivery Devices Market Forecast by End-User
10.7 Germany Liposomal Drug Delivery Devices Market Forecast, 2022-2032
10.7.1 Germany is Ideal Location for the Development & Manufacturing of High Quality Research Intensive Products
10.7.2 Growing Demand for Liposomal Based Therapy to Boost Market Growth
10.7.3 Evonik Has Launched Next-Generation LIPEX® Extruder for Fast and Effective Liposomal Drug Manufacturing
10.7.4 COVID-19 Impact Recovery Scenarios (V, U, W, L): Germany Liposomal Drug Delivery Devices Market Forecast, 2022-2032
10.8 UK Liposomal Drug Delivery Devices Market Forecast, 2022-2032
10.8.1 T&T Scientific Has Introduced Low-cost Fully-assemble Liposome Extrusion Device
10.8.2 Acquisition of Avanti Polar Lipids, Inc. by Croda International PLC
10.8.3 Rising Cancer Burden to Fuel Market Growth
10.8.4 Invasive Fungal Diseases to Fuel Regional Market Growth
10.8.5 COVID-19 Impact Recovery Scenarios (V, U, W, L): UK Liposomal Drug Delivery Devices Market Forecast, 2022-2032
10.9 France Liposomal Drug Delivery Devices Market Forecast, 2022-2032
10.9.1 Growing Need to Strengthen French Biotech Sector to Fuel Regional Liposomes Drug Delivery Devices Market Growth
10.9.2 Rising Incidence of Chronic Diseases to Boost Regional Growth
10.9.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): France Liposomal Drug Delivery Devices Market Forecast, 2022-2032
10.10 Italy Liposomal Drug Delivery Devices Market Forecast, 2022-2032
10.10.1 Italy is a Major Pharmaceutical Manufacturer across Europe
10.10.2 Growing Research Activities to Boost Regional Growth
10.10.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Italy Liposomal Drug Delivery Devices Market Forecast, 2022-2032
10.11 Spain Liposomal Drug Delivery Devices Market Forecast, 2022-2032
10.11.1 Growing Burden of Cancer to Fuel Market Growth
10.11.2 GP Pharma’s Liposomes for Injection
10.11.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Spain Liposomal Drug Delivery Devices Market Forecast, 2022-2032
10.12 Russia Liposomal Drug Delivery Devices Market Forecast, 2022-2032
10.12.1 Government Initiatives to Offer Lucrative Growth Prospects for Russian Liposomal Drug Delivery Devices Market Players
10.12.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Russia Liposomal Drug Delivery Devices Market Forecast, 2022-2032
10.13 Rest of Europe Liposomal Drug Delivery Devices Market Forecast, 2022-2032
10.13.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Europe Liposomal Drug Delivery Devices Market Forecast, 2022-2032
11 Asia Pacific Liposomal Drug Delivery Devices Market
11.1 Introduction
11.2 Asia Pacific Liposomal Drug Delivery Devices Market by Country, Forecast 2022-2032
11.3 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Type
11.4 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Technology
11.5 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by Application
11.6 Asia Pacific Liposomal Drug Delivery Devices Market Forecast by End-User
11.7 Japan Liposomal Drug Delivery Devices Market Forecast, 2022-2032
11.7.1 Japanese Pharmaceutical Sector is Undergoing Significant Changes
11.7.2 Fujifilm Begins Contract Services of Process Development and Manufacturing of Liposomes Formulation
11.7.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Japan Liposomal Drug Delivery Devices Market Forecast, 2022-2032
11.8 China Liposomal Drug Delivery Devices Market Forecast, 2022-2032
11.8.1 Healthcare Reforms by Chinese Government to Offer Lucrative Growth Opportunities
11.8.2 Luye Pharma Group Announced Approval of Dulaglutide Injection (BA5101)
11.8.3 TLC Biosciences Announces Results of TLC599 Phase 2
11.8.4 COVID-19 Impact Recovery Scenarios (V, U, W, L): China Liposomal Drug Delivery Devices Market Forecast, 2022-2032
11.9 India Liposomal Drug Delivery Devices Market Forecast, 2022-2032
11.9.1 Pharmaceutical businesses across India have been increasing their capabilities
11.9.2 Amphotericin B Liposomal Injection Approval by DGCI (Drug Controller General of India)
11.9.3 Ageing Population to Boost Market Growth
11.9.4 COVID-19 Impact Recovery Scenarios (V, U, W, L): India Liposomal Drug Delivery Devices Market Forecast, 2022-2032
11.10 Australia Liposomal Drug Delivery Devices Market Forecast, 2022-2032
11.10.1 UNSW Team Taps Light-Activated Liposomes for Safer CRISPR Delivery
11.10.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Australia Liposomal Drug Delivery Devices Market Forecast, 2022-2032
11.11 South Korea Liposomal Drug Delivery Devices Market Forecast, 2022-2032
11.11.1 South Korean Researchers Ready to Commercialize Technology for Mass Production of Liposomes
11.11.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): South Korea Liposomal Drug Delivery Devices Market Forecast, 2022-2032
11.12 Rest of Asia Pacific Liposomal Drug Delivery Devices Market Forecast, 2022-2032
11.12.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Liposomal Drug Delivery Devices Market Forecast, 2022-2032
12 Latin America Liposomal Drug Delivery Devices Market
12.1 Introduction
12.2 Latin America Liposomal Drug Delivery Devices Market by Country, Forecast 2022-2032
12.3 Latin America Liposomal Drug Delivery Devices Market Forecast by Type
12.4 Latin America Liposomal Drug Delivery Devices Market Forecast by Technology
12.5 Latin America Liposomal Drug Delivery Devices Market Forecast by Application
12.6 Latin America Liposomal Drug Delivery Devices Market Forecast by End-User
12.7 Brazil Liposomal Drug Delivery Devices Market Forecast, 2022-2032
12.7.1 Brazil Currently Dominates the Latin American Liposomal Drug Delivery Devices Market
12.7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Brazil Liposomal Drug Delivery Devices Market Forecast, 2022-2032
12.8 Mexico Liposomal Drug Delivery Devices Market Forecast, 2022-2032
12.8.1 Implementations of Health Reforms to Offer Lucrative Growth Opportunities for Market Players
12.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Mexico Liposomal Drug Delivery Devices Market Forecast, 2022-2032
12.9 Rest of Latin America Liposomal Drug Delivery Devices Market Forecast, 2022-2032
12.9.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Latin America Liposomal Drug Delivery Devices Market Forecast, 2022-2032
13 Middle East and Africa Liposomal Drug Delivery Devices Market
13.1 Introduction
13.2 Middle East and Africa Liposomal Drug Delivery Devices Market by Country, Forecast 2022-2032
13.3 Middle East and Africa Liposomal Drug Delivery Devices Market Forecast by Type
13.4 Middle East and Africa Liposomal Drug Delivery Devices Market Forecast by Technology
13.5 Middle East and Africa Liposomal Drug Delivery Devices Market Forecast by Application
13.6 Middle East and Africa Liposomal Drug Delivery Devices Market Forecast by End-User
13.7 GCC Liposomal Drug Delivery Devices Market Forecast, 2022-2032
13.7.1 Growing Healthcare Investments to Boost Regional Growth Through 2032
13.7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): GCC Liposomal Drug Delivery Devices Market Forecast, 2022-2032
13.8 South Africa Liposomal Drug Delivery Devices Market Forecast, 2022-2032
13.8.1 Growing Burden of Infectious Diseases to Fuel Market Growth over the Next Decade
13.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): South Africa Liposomal Drug Delivery Devices Market Forecast, 2022-2032
13.9 Rest of Middle East and Africa Liposomal Drug Delivery Devices Market Forecast, 2022-2032
13.9.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Middle East and Africa Liposomal Drug Delivery Devices Market Forecast, 2022-2032
14 Company Profiles
14.1 Company Ranking, 2021
14.2 Recent Developments
14.3 Takeda Pharmaceutical Company Limited
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.4 Product Benchmarking
14.4 Novartis AG
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.4 Product Benchmarking
14.4.5 Recent Developments
14.5 Luye Pharma Group
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Product Benchmarking
14.5.4 Recent Developments
14.6 Ipsen Pharma
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.4 Product Benchmarking
14.6.5 Recent Developments
14.7 Celsion, Inc.
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Product Benchmarking
14.7.4 Recent Developments
14.8 Galen Limited
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Product Benchmarking
14.9 Astellas Pharma, Inc.
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.4 Product Benchmarking
14.9.5 Recent Developments
14.10 Acrotech Biopharma, Inc.
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Product Benchmarking
14.11 Fudan-Zhangjiang
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Product Benchmarking
14.12 Pacira
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis
14.12.4 Product Benchmarking
14.12.5 Recent Developments
14.13 Creative Biolabs
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Product Benchmarking
14.14 Precision NanoSystems Inc.
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Product Benchmarking
14.15 Encapsula NanoSciences LLC
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Product Benchmarking
14.16 Avanti Polar Lipids, Inc.
14.16.1 Company Snapshot
14.16.2 Company Overview
14.16.3 Product Benchmarking
14.17 Viatris Inc.
14.17.1 Company Snapshot
14.17.2 Company Overview
14.17.3 Financial Analysis
14.17.4 Product Benchmarking
14.18 Merrimack Pharmaceuticals, Inc.
14.18.1 Company Snapshot
14.18.2 Company Overview
14.18.3 Product Benchmarking
15 Conclusion and Recommendations
15.1 Concluding Remarks
15.2 Recommendations for Market Players
List of Tables
Table 1 Global Liposomal Drug Delivery Devices Market Snapshot, 2022 & 2032 (US$ million, CAGR %)
Table 2 Candidate Liposomal Vaccine Formulations
Table 3 List of Clinically Approved Nanomedicines for Cancer Treatment
Table 4 Global Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR%)
Table 5 Liposome-based Drugs on Market
Table 6 Liposome-based Drugs in Clinical Trails
Table 7 Global Liposomal Drug Delivery Devices Market Forecast for Liposomal Doxorubicin Segment, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 8 Global Liposomal Drug Delivery Devices Market Forecast for Liposomal Doxorubicin Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 9 Global Liposomal Drug Delivery Devices Market Forecast for Liposomal Doxorubicin Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 10 Global Liposomal Drug Delivery Devices Market Forecast for Liposomal Doxorubicin Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 11 Global Liposomal Drug Delivery Devices Market Forecast for Liposomal Doxorubicin Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 12 Global Liposomal Drug Delivery Devices Market Forecast for Liposomal Paclitaxel Segment, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 13 Global Liposomal Drug Delivery Devices Market Forecast for Liposomal Paclitaxel Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 14 Global Liposomal Drug Delivery Devices Market Forecast for Liposomal Paclitaxel Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 15 Global Liposomal Drug Delivery Devices Market Forecast for Liposomal Paclitaxel Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 16 Global Liposomal Drug Delivery Devices Market Forecast for Liposomal Paclitaxel Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 17 Global Liposomal Drug Delivery Devices Market Forecast for Liposomal Amphotericin B Segment, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 18 Global Liposomal Drug Delivery Devices Market Forecast for Liposomal Amphotericin B Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 19 Global Liposomal Drug Delivery Devices Market Forecast for Liposomal Amphotericin B Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 20 Global Liposomal Drug Delivery Devices Market Forecast for Liposomal Amphotericin B Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 21 Global Liposomal Drug Delivery Devices Market Forecast for Liposomal Amphotericin B Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 22 Global Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ million, AGR%, CAGR%)
Table 23 Global Liposomal Drug Delivery Devices Market Forecast for Stealth Liposome Technology Segment, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 24 Global Liposomal Drug Delivery Devices Market Forecast for Stealth Liposome Technology Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 25 Global Liposomal Drug Delivery Devices Market Forecast for Stealth Liposome Technology Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 26 Global Liposomal Drug Delivery Devices Market Forecast for Stealth Liposome Technology Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 27 Global Liposomal Drug Delivery Devices Market Forecast for Stealth Liposome Technology Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 28 Global Liposomal Drug Delivery Devices Market Forecast for Non-PEGylated Liposome Technology Segment, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 29 Global Liposomal Drug Delivery Devices Market Forecast for Non-PEGylated Liposome Technology Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 30 Global Liposomal Drug Delivery Devices Market Forecast for Non-PEGylated Liposome Technology Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 31 Global Liposomal Drug Delivery Devices Market Forecast for Non-PEGylated Liposome Technology Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 32 Global Liposomal Drug Delivery Devices Market Forecast for Non-PEGylated Liposome Technology Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 33 Global Liposomal Drug Delivery Devices Market Forecast for DepoFoam Liposome Technology Segment, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 34 Global Liposomal Drug Delivery Devices Market Forecast for DepoFoam Liposome Technology Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 35 Global Liposomal Drug Delivery Devices Market Forecast for DepoFoam Liposome Technology Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 36 Global Liposomal Drug Delivery Devices Market Forecast for DepoFoam Liposome Technology Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 37 Global Liposomal Drug Delivery Devices Market Forecast for DepoFoam Liposome Technology Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 38 Global Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR%)
Table 39 Global Liposomal Drug Delivery Devices Market Forecast for Fungal Diseases Segment, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 40 Global Liposomal Drug Delivery Devices Market Forecast for Fungal Diseases Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 41 Global Liposomal Drug Delivery Devices Market Forecast for Fungal Diseases Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 42 Global Liposomal Drug Delivery Devices Market Forecast for Fungal Diseases Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 43 Global Liposomal Drug Delivery Devices Market Forecast for Fungal Diseases Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 44 FDA-approval drug products of injection delivery based on liposome technology (liposome, nanoparticle, nanosuspension, microemulsion, microsphere)
Table 45 Global Liposomal Drug Delivery Devices Market Forecast for Cancer Therapy Segment, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 46 Global Liposomal Drug Delivery Devices Market Forecast for Cancer Therapy Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 47 Global Liposomal Drug Delivery Devices Market Forecast for Cancer Therapy Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 48 Global Liposomal Drug Delivery Devices Market Forecast for Cancer Therapy Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 49 Global Liposomal Drug Delivery Devices Market Forecast for Cancer Therapy Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 50 Global Liposomal Drug Delivery Devices Market Forecast for Pain Management Segment, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 51 Global Liposomal Drug Delivery Devices Market Forecast for Pain Management Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 52 Global Liposomal Drug Delivery Devices Market Forecast for Pain Management Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 53 Global Liposomal Drug Delivery Devices Market Forecast for Pain Management Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 54 Global Liposomal Drug Delivery Devices Market Forecast for Pain Management Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 55 List of Pipeline Candidate Vaccine Formulations
Table 56 Global Liposomal Drug Delivery Devices Market Forecast for Viral Vaccines Segment, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 57 Global Liposomal Drug Delivery Devices Market Forecast for Viral Vaccines Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 58 Global Liposomal Drug Delivery Devices Market Forecast for Viral Vaccines Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 59 Global Liposomal Drug Delivery Devices Market Forecast for Viral Vaccines Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 60 Global Liposomal Drug Delivery Devices Market Forecast for Viral Vaccines Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 61 Encapsulation of Photosensitizers (PSs) into Liposomes in Cancer PDT
Table 62 Global Liposomal Drug Delivery Devices Market Forecast for Photodynamic Therapy Segment, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 63 Global Liposomal Drug Delivery Devices Market Forecast for Photodynamic Therapy Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 64 Global Liposomal Drug Delivery Devices Market Forecast for Photodynamic Therapy Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 65 Global Liposomal Drug Delivery Devices Market Forecast for Photodynamic Therapy Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 66 Global Liposomal Drug Delivery Devices Market Forecast for Photodynamic Therapy Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 67 Global Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ million, AGR%, CAGR%)
Table 68 Global Liposomal Drug Delivery Devices Market Forecast for Hospitals Segment, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 69 Global Liposomal Drug Delivery Devices Market Forecast for Hospitals Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 70 Global Liposomal Drug Delivery Devices Market Forecast for Hospitals Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 71 Global Liposomal Drug Delivery Devices Market Forecast for Hospitals Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 72 Global Liposomal Drug Delivery Devices Market Forecast for Hospitals Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 73 Global Liposomal Drug Delivery Devices Market Forecast for Diagnostic Centers Segment, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 74 Global Liposomal Drug Delivery Devices Market Forecast for Diagnostic Centers Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 75 Global Liposomal Drug Delivery Devices Market Forecast for Diagnostic Centers Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 76 Global Liposomal Drug Delivery Devices Market Forecast for Diagnostic Centers Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 77 Global Liposomal Drug Delivery Devices Market Forecast for Diagnostic Centers Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 78 Global Liposomal Drug Delivery Devices Market Forecast for Ambulatory Surgery Centers/Clinics Segment, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 79 Global Liposomal Drug Delivery Devices Market Forecast for Ambulatory Surgery Centers/Clinics Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 80 Global Liposomal Drug Delivery Devices Market Forecast for Ambulatory Surgery Centers/Clinics Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 81 Global Liposomal Drug Delivery Devices Market Forecast for Ambulatory Surgery Centers/Clinics Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 82 Global Liposomal Drug Delivery Devices Market Forecast for Ambulatory Surgery Centers/Clinics Segment, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 83 Global Liposomal Drug Delivery Devices Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 84 Global Liposomal Drug Delivery Devices Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 85 Global Liposomal Drug Delivery Devices Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 86 Global Liposomal Drug Delivery Devices Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 87 Global Liposomal Drug Delivery Devices Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 88 North America Liposomal Drug Delivery Devices Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR%)
Table 89 North America Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR%)
Table 90 North America Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 91 North America Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 92 North America Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 93 North America Liposomal Drug Delivery Devices Market Forecast by Type, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 94 North America Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ million, AGR%, CAGR%)
Table 95 North America Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 96 North America Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 97 North America Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 98 North America Liposomal Drug Delivery Devices Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 99 North America Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR%)
Table 100 North America Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 101 North America Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 102 North America Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 103 North America Liposomal Drug Delivery Devices Market Forecast by Application, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 104 North America Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ million, AGR%, CAGR%)
Table 105 North America Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 106 North America Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 107 North America Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 108 North America Liposomal Drug Delivery Devices Market Forecast by End-User, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 109 U.S. Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 110 U.S. Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 111 U.S. Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 112 U.S. Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 113 U.S. Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 114 Canada Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 115 Canada Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 116 Canada Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 117 Canada Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 118 Canada Liposomal Drug Delivery Devices Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 119 Europe Liposomal Drug De
